差價合約是複雜的工具,並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損您應該考慮自己是否了解差價合約的運作方式,以及您是否有能力承擔損失資金的高風險。

掃碼下載 iOS 和安卓 APP

交易 Inozyme Pharma, Inc. - INZY CFD

-
0%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 -
多頭倉位隔夜費用

Long position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.030779%
空頭倉位隔夜費用

Short position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.013666%
隔夜費時間 22:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* N/A
開盤價* N/A
1 年變化* N/A
日範圍* N/A
52 周範圍 0.99-7.98
平均交易量(10 天) 476.60K
平均交易量(3 個月) 4.20M
市值 111.89M
市盈率 -100.00K
流通股 40.39M
收入 N/A
EPS -2.26
股息(收益率 %) N/A
貝塔 -100.00K
下一個財報發布日期 Mar 13, 2023

所有數據都是由Refinitiv提供的, 除了標有星號的數據, 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開

Inozyme Pharma, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • 年度
  • 每季度
2018 2019 2020 2021
總收入 0 0 0 0
總營業費用 11.593 20.806 57.041 56.646
銷售/一般/行政費用,總計 3.494 4.586 10.548 18.926
研究與開發 8.099 16.22 46.493 37.72
營業收入 -11.593 -20.806 -57.041 -56.646
利息收入(費用),非經營淨值 0.284 1.106 0.37 0.211
其他,淨值 4.345 -0.024 0.247 -0.189
稅前淨收入 -6.964 -19.724 -56.424 -56.624
稅後淨收入 -6.964 -19.724 -56.424 -56.624
未計算非常項目前的淨收益 -6.964 -19.724 -56.424 -56.624
淨收入 -6.964 -19.724 -56.424 -56.624
普通股股東可獲收益 (不含非經常性項目) -6.964 -19.724 -56.424 -56.624
普通股股東可獲收益 (含非經常性項目) -6.964 -19.724 -56.424 -56.624
攤薄淨收入 -6.964 -19.724 -56.424 -56.624
攤薄後加權平均股 20.3148 20.3148 11.0365 23.5583
扣除特別項目的每股攤薄盈利 -0.3428 -0.97092 -5.11249 -2.40357
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 -0.3428 -0.97092 -5.11249 -2.40357
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
總收入 0 0 0 0 0
總營業費用 10.972 12.655 14.262 18.757 16.839
銷售/一般/行政費用,總計 4.369 4.435 4.916 5.206 5.025
研究與開發 6.603 8.22 9.346 13.551 11.814
營業收入 -10.972 -12.655 -14.262 -18.757 -16.839
利息收入(費用),非經營淨值 0.063 0.058 0.047 0.043 0.06
其他,淨值 -0.141 0.057 -0.065 -0.04 -0.105
稅前淨收入 -11.05 -12.54 -14.28 -18.754 -16.884
稅後淨收入 -11.05 -12.54 -14.28 -18.754 -16.884
未計算非常項目前的淨收益 -11.05 -12.54 -14.28 -18.754 -16.884
淨收入 -11.05 -12.54 -14.28 -18.754 -16.884
普通股股東可獲收益 (不含非經常性項目) -11.05 -12.54 -14.28 -18.754 -16.884
普通股股東可獲收益 (含非經常性項目) -11.05 -12.54 -14.28 -18.754 -16.884
攤薄淨收入 -11.05 -12.54 -14.28 -18.754 -16.884
攤薄後加權平均股 23.4295 23.4906 23.6435 23.6673 23.6863
扣除特別項目的每股攤薄盈利 -0.47163 -0.53383 -0.60397 -0.7924 -0.71282
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.47163 -0.53383 -0.60397 -0.7924 -0.71282
  • 年度
  • 每季度
2018 2019 2020 2021
流動資産總額 43.267 47.46 150.979 115.342
現金和短期投資 43.163 47.132 147.697 111.801
現金等價物 35.966 31.605 28.04 23.316
短期投資 7.197 15.527 119.657 88.485
應收賬款總額,淨額 0.031 0.104 0.155 0.062
Prepaid Expenses 0.073 0.224 3.127 3.479
Total Assets 43.543 47.944 169.363 123.541
Property/Plant/Equipment, Total - Net 0.242 0.298 2.648 4.436
Property/Plant/Equipment, Total - Gross 0.269 0.408 2.975 5.437
Accumulated Depreciation, Total -0.027 -0.11 -0.327 -1.001
Other Long Term Assets, Total 0.034 0.186 3.537 3.763
Total Current Liabilities 2.389 3.236 9.973 11.633
Accounts Payable 0.984 0.901 3.069 2.394
Accrued Expenses 1.405 2.335 6.625 9.239
Notes Payable/Short Term Debt 0 0 0 0
Total Liabilities 2.389 3.236 11.26 14.273
Total Long Term Debt 0 0 0 0
Total Equity 41.154 44.708 158.103 109.268
Preferred Stock - Non Redeemable, Net 55.029 77.927
Common Stock 0.001 0.001 0.002 0.002
Additional Paid-In Capital 1.054 1.427 249.175 256.948
Retained Earnings (Accumulated Deficit) -14.928 -34.652 -91.076 -147.7
Other Equity, Total -0.002 0.005 0.002 0.018
Total Liabilities & Shareholders’ Equity 43.543 47.944 169.363 123.541
Total Common Shares Outstanding 20.3148 20.3148 23.385 23.6726
Total Preferred Shares Outstanding 72.4164
Long Term Investments 12.199 0
Other Current Liabilities, Total 0.279 0
Other Liabilities, Total 1.287 2.64
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
流動資産總額 148.041 140.962 130.579 115.342 100.583
現金和短期投資 145.086 137.464 125.283 111.801 97.773
現金等價物 16.486 26.239 27.229 23.316 31.943
短期投資 128.6 111.225 98.054 88.485 65.83
應收賬款總額,淨額 0.122 0.095 0.073 0.062 0.048
Prepaid Expenses 2.833 3.403 5.223 3.479 2.762
Total Assets 158.915 148.259 137.746 123.541 108.931
Property/Plant/Equipment, Total - Net 5.029 4.859 4.743 4.436 4.184
Property/Plant/Equipment, Total - Gross 5.514 5.511 5.562 5.437 5.363
Accumulated Depreciation, Total -0.485 -0.652 -0.819 -1.001 -1.179
Long Term Investments 2.548 0 0 0
Other Long Term Assets, Total 3.297 2.438 2.424 3.763 4.164
Total Current Liabilities 6.832 6.972 8.943 11.633 12.26
Accounts Payable 1.709 0.796 0.626 2.394 2.2
Accrued Expenses 5.123 6.176 8.317 9.239 10.06
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 10.026 9.985 11.772 14.273 14.702
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 3.194 3.013 2.829 2.64 2.442
Total Equity 148.889 138.274 125.974 109.268 94.229
Common Stock 0.002 0.002 0.002 0.002 0.002
Additional Paid-In Capital 251.001 252.92 254.915 256.948 258.94
Retained Earnings (Accumulated Deficit) -102.126 -114.666 -128.946 -147.7 -164.584
Other Equity, Total 0.012 0.018 0.003 0.018 -0.129
Total Liabilities & Shareholders’ Equity 158.915 148.259 137.746 123.541 108.931
Total Common Shares Outstanding 23.4737 23.5706 23.6647 23.6726 23.8184
Other Current Liabilities, Total 0 0 0
Preferred Stock - Non Redeemable, Net 0 0
  • 年度
  • 每季度
2018 2019 2020 2021
淨收入/起跑線 -6.964 -19.724 -56.424 -56.624
經營活動産生的現金 -9.437 -18.81 -35.974 -48.153
經營活動産生的現金 0.026 0.083 0.217 0.674
非現金物品 -3.93 0.23 20.344 7.712
營運資金的變化 1.431 0.601 -0.111 0.085
投資活動産生的現金 9.006 -8.391 -117.179 42.796
資本支出 -0.259 -0.139 -0.568 -0.397
其他投資現金流量項目,總計 9.265 -8.252 -116.611 43.193
融資活動産生的現金 31.945 22.97 149.812 0.609
股票的發行(報廢),淨額 31.945 22.97 149.812 0.609
現金淨變化 31.514 -4.231 -3.341 -4.724
外彙效應 0.024
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -11.05 -23.59 -37.87 -56.624 -16.884
Cash From Operating Activities -12.376 -22.409 -34.709 -48.153 -14.16
Cash From Operating Activities 0.158 0.325 0.492 0.674 0.178
Non-Cash Items 1.725 3.689 5.567 7.712 1.779
Changes in Working Capital -3.209 -2.833 -2.898 0.085 0.767
Cash From Investing Activities 0.573 20.247 33.309 42.796 22.562
Capital Expenditures -0.088 -0.278 -0.357 -0.397 -0.017
Other Investing Cash Flow Items, Total 0.661 20.525 33.666 43.193 22.579
Cash From Financing Activities 0.249 0.361 0.598 0.609 0.24
Issuance (Retirement) of Stock, Net 0.249 0.361 0.598 0.609 0.24
Net Change in Cash -11.554 -1.801 -0.811 -4.724 8.627
Foreign Exchange Effects -0.009 0.024 -0.015
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Longitude Capital Management Co., LLC Venture Capital 10.3341 4174379 1355000 2022-04-19 LOW
Sofinnova Investments, Inc Venture Capital 9.0491 3655308 0 2022-09-30 MED
Deep Track Capital LP Hedge Fund 8.0457 3250000 0 2022-09-30 MED
Rock Springs Capital Management LP Hedge Fund 6.9505 2807618 167562 2022-09-30 LOW
VR Adviser, LLC Venture Capital 6.7088 2709987 0 2022-09-30 LOW
Pivotal Bioventure Partners Investment Advisor LLC Investment Advisor 6.5879 2661154 0 2022-09-30 LOW
Adage Capital Management, L.P. Hedge Fund 6.4283 2596672 50000 2022-09-30 LOW
New Enterprise Associates (NEA) Venture Capital 6.0513 2444379 0 2022-09-30 LOW
Deerfield Management Company, L.P. Hedge Fund 5.1751 2090436 -605936 2022-09-30 MED
Cowen Investment Management LLC Investment Advisor/Hedge Fund 4.942 1996277 -37525 2022-09-30 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.3249 1343063 -11153 2022-09-30 LOW
Sphera Funds Management Ltd. Hedge Fund 2.909 1175058 9458 2022-09-30 MED
Janus Henderson Investors Investment Advisor/Hedge Fund 1.7467 705577 -224379 2022-09-30 LOW
BioImpact Capital LLC Investment Advisor/Hedge Fund 1.6367 661144 -3836 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 1.5086 609380 -439 2022-09-30 LOW
Laurion Capital Management LP Hedge Fund 0.6729 271800 0 2022-09-30 HIGH
Bolte (Axel) Individual Investor 0.6483 261890 3315 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.6395 258321 -1011 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5785 233685 16760 2022-09-30 LOW
Jungles (Steven J) Individual Investor 0.4982 201262 159226 2022-04-19

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+500000+

Traders

93000+

Active clients monthly

$57000000+

Monthly investing volume

$31000000+

Withdrawn each month

差價合約交易計算器

計算您的假設損益

交易佣金
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
槓桿
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
打開

關閉

做空 做多
Industry: Biotechnology & Medical Research (NEC)

321 Summer Street
Suite 400
BOSTON
MASSACHUSETTS 02210
US

收入報表

  • Annual
  • Quarterly

人們也觀看

XRP/USD

0.40 Price
-0.370% 1D Chg, %
多頭倉位隔夜費用 -0.0500%
空頭倉位隔夜費用 0.0140%
隔夜費時間 22:00 (UTC)
價差 0.00332

Natural Gas

2.66 Price
+1.030% 1D Chg, %
多頭倉位隔夜費用 -0.1046%
空頭倉位隔夜費用 0.0738%
隔夜費時間 22:00 (UTC)
價差 0.005

BTC/USD

23,185.60 Price
-0.180% 1D Chg, %
多頭倉位隔夜費用 -0.0500%
空頭倉位隔夜費用 0.0140%
隔夜費時間 22:00 (UTC)
價差 60.00

Oil - Crude

78.41 Price
+0.760% 1D Chg, %
多頭倉位隔夜費用 -0.0221%
空頭倉位隔夜費用 0.0069%
隔夜費時間 22:00 (UTC)
價差 0.03

還在尋找值得信賴的經紀商?

加入全球 500.000 多名交易者,選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易